Clinical Trials · NCT02245620
A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 41
- Start date
- Jan 2015
- Locations
- 1 site, United States
- Primary endpoint
- Change From Baseline in ATPmax (Maximal ATP Synthetic Rate)